The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: A 1-year cross-sectional study in a referral area with 260,000 inhabitants

American Journal of Gastroenterology

Volumn 97, Issue 10, 2002, Pages 2524-2529

  Mäntynen, Timo ^a,d   Färkkilä, Martti ^b,d   Kunnamo, Ilkka ^a,d   Mecklin, Jukka Pekka ^c,d   Juhola, Matti ^c,d   Voutilainen, Markku ^c,d  

^a Karstula Health Care Center   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; ESOPHAGUS ULCER; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENERAL PRACTITIONER; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RISK FACTOR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CROSS-SECTIONAL STUDIES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 0036794194     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04392-7     Document Type: Article

References (26)

1. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
2. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux. A population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
3. Dent J. Gastro-oesophageal reflux disease. Digestion 1998;59:433-45.
4. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998;10:119-24.
5. Glise H, Wiklund I. Measurement of the impact of heartburn and dyspepsia on quality of life. Aliment Pharmacol Ther 1997;11(suppl 2):73-7.
6. Botterweck AAM, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54.
7. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
8. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
9. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997;32:965-73.
10. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management. Gut 1999;44(suppl 2): S3-16.
11. Voutilainen M, Sipponen P, Mecklin J-P, et al. Gastroesophageal reflux disease. Prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000;61:6-13.
12. Conio M, Cameron AJ, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001;48:304-9.
13. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
14. Bramble MG, Suvakovic Z, Hungin APS. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000;46:464-7.
15. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus. Gastroenterology 2000;119:333-8.
16. Van der Burgh A, Dees J, Hop WCJ, et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
17. MacDonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: Observational study. Br Med J 2000;321:1252-5.
18. Gudlaugsdottir S, van Blankenstein M, Dees J, et al. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Eur J Gastroenterol Hepatol 2001;13:639-45.
19. Rana PS, Johnston DA. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: Implications for endoscopic surveillance. Dis Esophagus 2000;13:28-31.
20. Farup PG, Hovde O, Torp R, et al. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern. Scand J Gastroenterol 1999;34:575-9.
21. O'Donnell CA. Variation in GP referral rates: What can we learn from the literature? Fam Pract 2000;17:462-71.
22. Hungin APS, Bramble MG, O'Callaghan H. Reasons for variations in the use of open access gastroscopy be general practitioners. Gut 1995;36:180-2.
23. Carlsson R, Galmiche JP, Dent J, et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of longterm omeprazole trials. Aliment Pharmacol Ther 1997;11:473-82.
24. Holloway RH, Dent J, Narielvala F, et al. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996;38:649-54.
25. Patti MG, Goldberg HI, Arcerito M, et al. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996;171:182-6.
26. Stål P, Lindberg G, Öst Å, et al. Gastroesophageal reflux in healthy subjects. Significance of endoscopic findings, histology, age, and sex. Scand J Gastroenterol 1999;34:121-8.